Reported 2 days ago
McKesson's stock rose 0.5% after the company reported a 19% year-over-year revenue increase to $90.8 billion for Q4 of fiscal 2025, along with a 15% rise in adjusted net profit. Despite strong growth, results were mixed as they fell short of analyst expectations. CEO Brian Tyler highlighted the core distribution and oncology platform's strength, while announcing plans to spin off its medical-surgical solutions unit into a new independent company. McKesson set optimistic guidance for adjusted net income for fiscal 2026.
Source: YAHOO